ML22027A670
| ML22027A670 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 01/27/2022 |
| From: | Jim Costedio SHINE Health. Illuminated, SHINE Technologies |
| To: | Document Control Desk, Office of Nuclear Reactor Regulation |
| Shared Package | |
| ML22027A669 | List: |
| References | |
| 2022-SMT-0021 | |
| Download: ML22027A670 (2) | |
Text
THIS LETTER CONTAINS PROPRIETARY AND EXPORT CONTROLLED INFORMATION IN ACCORDANCE WITH 10 CFR 2.390 contains security-related information.
Withhold from public disclosure under 10 CFR 2.390.
Upon removal of Enclosure 1 this letter is uncontrolled.
3400 Innovation Ct.
- Janesville, WI 53546
- 877.512.6554
- info@shinemed.com
- www.SHINEtechnologies.com
January 27, 2022 2022-SMT-0021 10 CFR 50.30 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555
References:
(1) SHINE Medical Technologies, LLC letter to the NRC, SHINE Medical Technologies, LLC Application for an Operating License, dated July 17, 2019 (ML19211C143)
SHINE Technologies, LLC Operating License Application Supplement No. 17 Submittal of a Revision to the SHINE Material Control and Accounting Plan Pursuant to 10 CFR Part 50.30, SHINE Technologies, LLC (SHINE) submitted an application for an operating license for a medical isotope production facility to be located in Janesville, WI (Reference 1). SHINE has determined that a revision to the Material Control and Accounting (MC&A) Plan is necessary to incorporate organizational changes and to include updates based on design progression of the medical isotope production facility.
This submittal contains information which SHINE requests to be withheld from public disclosure, including proprietary information in accordance with 10 CFR 2.390(a)(4), export controlled information (ECI) in accordance with 10 CFR 2.390(a)(3), and security-related information (SRI) in accordance with 10 CFR 2.390(d). SRI was identified utilizing the guidance contained in Regulatory Issue Summary (RIS) 2005-31, Revision 1.
provides a non-public version of the SHINE Material Control and Accounting (MC&A) Plan. Enclosure 1 contains proprietary information, a subset of which has been determined to be ECI, as well as SRI. SHINE requests that the NRC withhold the Enclosure 1, in its entirety, from public disclosure under 10 CFR 2.390.
provides an affidavit supporting the proprietary treatment of the SHINE proprietary information contained in Enclosure 1, pursuant to 10 CFR 2.390. SHINE requests that the NRC withhold Enclosure 1 from public disclosure under 10 CFR 2.390. Upon removal of Enclosure 1, this letter is uncontrolled.
If you have any questions, please contact Mr. Jeff Bartelme, Director of Licensing, at 608/210-1735.
Document Control Desk Page 2
I declare under the penalty of perjury that the foregoing is true and correct.
Executed on January 27, 2022.
Very truly yours, James Costedio Vice President of Regulatory Affairs and Quality SHINE Technologies, LLC Docket No. 50-608 Enclosure cc:
Project Manager, USNRC SHINE General Counsel Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health (w/o Enclosure 1)